Temsirolimus
Temsirolimus is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.
| Catalog Number | T2145 |
| Alternative Name(s) | NSC 683864 , CCI-779 |
| Research Area | Apoptosis|||PI3K/Akt/mTOR signaling|||Autophagy |
| Molecular Formula | C56H87NO16 |
| CAS# | 162635-04-3 |
| Purity | 97.69% |
| SMILES | CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C/C=C/C=C(C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OC(=O)C(C)(CO)CO |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Temsirolimus |
| Additional Information | https://www.targetmol.com/datasheet/T2145 |